The GLP-1 Revolution: Addressing India’s Unique Obesity Crisis
A New Frontier in Metabolic Health As India grapples with its status as the world’s diabetes capital, a wave of affordable GLP-1 receptor agonist generics is entering the market, promising to reshape how the country approaches obesity and metabolic health. These medications, once reserved for the affluent, are now being integrated into clinical and even…